1-3 of 3
Kristin Ivanovski, RN
Close
Sort by
Journal Articles

Two Year Update of Phase II Trial of Pembrolizumab, Lenalidomide and Dexamethasone As Post -Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Meena Bansal, DO, David S. Siegel, Jaeil Ahn, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Andrew L. Pecora, MD, Elli Gourna Paleoudis, PhD, Scott D. Rowley, MD, Michele L. Donato, MD, Robert Korngold, PhD, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1911.
https://doi.org/10.1182/blood-2019-125155
Published: 2019
Journal Articles

A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone As Post Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Noa Biran, MD, Tracy Andrews, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Joshua Zenreich, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Robert Korngold, PhD, David Siegel, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1831.
https://doi.org/10.1182/blood.V130.Suppl_1.1831.1831
Published: 2017
Journal Articles

Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma

Noa Biran, MD, David H. Vesole, MD PhD, Shijia Zhang, MD PhD, Joshua R. Richter, MD, Yen-Hong Kuo, PhD, Linda Schmidt, RN BSN MSN OCN CNL, Laura McBride, RN, BSN, OCN, CCRP, Palka Anand, BSN, Kristin Ivanovski, RN, Amy Pierre, RN, MSN, APN, Susan Kumka, RN, MSN, APN, Carmela Cuccurullo, RN, MSN, APN, David S. Siegel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5685.
https://doi.org/10.1182/blood.V128.22.5685.5685
Published: 2016